30 days refund guarantee
Chikungunya and Zika Viruses :Global Emerging Health Threats
Chikungunya and Zika Viruses :Global Emerging Health Threats
paperback
Published:
1 June, 2018
paperback
Published:
1 June, 2018
FREE Delivery by
Mon, April 20 - Tue, April 21
Order within
0
Condition:
NEW
£97.97
RRP
£127.00
You save £29.03 (23%)
Available
20
in stock
FREE Returns within 30 days
Popular Books by Ann Powers
View All Books by Ann Powers
Description
Chikungunya and Zika Viruses: Global Emerging Health Threats is the go-to resource for both historical and current information on this important virus that is rapidly increasing its global range. Epidemics since 2005 have spread from Africa and Asia, and through Europe, and an ongoing epidemic has caused nearly two million cases in the Americas. It causes severe crippling arthritis, with symptoms lasting for months or years. As no vaccine or treatment is available, there is international interest in the virus, thus funding opportunities for research have dramatically increased. This book presents our understanding of the virus, bringing comprehensive knowledge in a single source.
More Details
| Type | Book |
|---|---|
| ISBN13 | 9780128118658 |
| ISBN10 | 0128118652 |
| Number Of Pages | 398 |
| Item Weight | 770 g |
| Publisher / Reseller | Elsevier Science Publishing Co Inc |
| Format | paperback |
See More +
Media Reviews
"The arguments are well grounded in classical work on evolution, but also on own research in blood cancers, and various observations across cancer research laboratories and clinic." --The Quarterly Review of Biology
Author's Bio
His research on chikungunya virus (CHIKV) preceded the ongoing epidemics that have recently infected over 1M people in the Americas. His development of patented infectious clones of this CHIKV placed his group at the forefront of research on this virus. They have distributed these research tools to other groups in an effort to better understand the epidemic. They have published over 30 papers on many aspects of chikungunya with collaborators from multiple institutes in different countries. Dr. Vanlandingham’s research is focused on the interactions between arboviruses, the mosquito vectors, and the vertebrate host. Infectious clone technology is used to identify the molecular determinants of infection of alphaviruses, bunyaviruses, and flaviviruses. There are currently four areas of research in her laboratory: 1) Rift Valley fever virus vaccine development; 2) examining vector competence of North American mosquitoes for Japanese encephalitis virus; 3) rationale vaccine design based on characterizing yellow fever virus to identify molecular determinants of infectivity and transmissibility by Ae. aegypti mosquitoes; and 4) assessing CHIKV-mosquito interactions and virus inactivation procedures to ensure blood transfusion safety.Dana obtained her B.S. and M.S. degrees from Colorado State University and her Ph.D from the Liverpool School of Tropical Medicine in 2006.